In comparison, we show that a 30-times lower dose of NVS-SM2 administered daily s.c. for five consecutive days, increased brain SMN protein by 4.5-fold in severe SMA and Het mice. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.